Home・Aandelen Lijst・OPKO Health Inc

OPKO Health Inc

Gesloten

SectorGezondheidszorg

1.56 5.41

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.55

Max

1.56

Belangrijke statistieken
By Trading Economics
Inkomsten	46M -8.4M
Verkoop	39M 164M
EPS	-0.01
Winstmarge	-5.145
Werknemers	2,275
EBITDA	40M 12M

Dividenden
By Acuity
Volgende Winsten	28 okt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	318M 1.2B
Vorige openingsprijs	-3.85
Vorige sluitingsprijs	1.56

Nieuwssentiment

By Acuity

31%

69%

60 / 339 Rangschikking in Healthcare

OPKO Health Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

11 sep 2026, 20:01 UTC

OPKO Health Inc shares are higher, continuing gains since Thursday's close. The stock rebounded after an early dip, with no specific news driving the movement.

9 sep 2026, 19:16 UTC

OPKO Health Inc. shares are lower today amid broader market pressures from rising oil prices above $100 per barrel and inflation concerns.

8 sep 2026, 23:36 UTC

No specific news was identified for OPKO Health Inc. Shares traded roughly flat after market hours, remaining near the upper end of their one-month range.

4 sep 2026, 20:07 UTC

OPKO Health Inc. shares are higher today, rebounding significantly after an initial dip and currently 12.75% above the 20-day moving average.

3 sep 2026, 21:02 UTC

OPKO Health Inc. is higher in after-hours trading, reflecting gains since Thursday's close amid declining Treasury yields and improved investor sentiment.

2 sep 2026, 23:46 UTC

OPKO Health Inc. shares were roughly flat during after-market hours, maintaining a significant one-month increase of about 29%.

1 sep 2026, 20:01 UTC

OPKO Health shares are higher today, remaining above their 20-day moving average amid rising oil prices and inflation concerns affecting the broader market.

28 aug 2026, 19:16 UTC

OPKO Health Inc. shares are lower today, having reached a session low. The stock remains within its one-month trading range and above the 20-day moving average.

27 aug 2026, 23:01 UTC

OPKO Health Inc. shares are higher in after-market trading, reflecting strong performance since Thursday's close and maintaining a position above its 20-day moving average.

26 aug 2026, 20:08 UTC

OPKO Health Inc shares are higher during Wednesday's session, maintaining a position above the 20-day moving average amid mixed broader market performance.

25 aug 2026, 19:36 UTC

OPKO Health Inc. shares are higher today, remaining above their 20-day moving average despite earlier fluctuations during the session.

24 aug 2026, 22:01 UTC

OPKO Health Inc. shares are lower in after-market trading, reflecting a shift in momentum since Monday's close. The stock remains above its 20-day moving average.

21 aug 2026, 23:56 UTC

OPKO Health Inc. shares declined in after-market trading, despite gains in major stocks as the broader market rebounded from earlier pressures.

20 aug 2026, 19:56 UTC

OPKO Health Inc. shares are higher today, maintaining a position above their 20-day moving average amid no specific company news identified.

19 aug 2026, 20:02 UTC

OPKO Health Inc shares are higher in Wednesday's session, recovering from an early dip. The stock remains above its 20-day moving average.

18 aug 2026, 19:16 UTC

OPKO Health Inc shares are lower amid broader market declines, influenced by rising Treasury yields and inflation concerns following a significant drop in housing starts.

17 aug 2026, 19:06 UTC

News

OPKO Health Inc. shares are lower today, continuing a decline since Friday. The company issued $125 million in senior secured notes linked to mazdutide royalties.

14 aug 2026, 19:36 UTC

OPKO Health Inc shares are lower amid broader market concerns following a reported decline in retail sales for July. The stock reached a session low earlier.

13 aug 2026, 23:01 UTC

OPKO Health shares lower in after-market trading, declining since Thursday's close amid mixed macroeconomic signals and uncertainty in the market.

12 aug 2026, 19:36 UTC

OPKO Health Inc shares are modestly higher, reflecting a positive market environment amid recent risk asset gains. Core CPI data aligns with forecasts, supporting steady interest rates.

11 aug 2026, 19:36 UTC

OPKO Health Inc shares are higher, maintaining a position above their 20-day moving average amid broader market sentiment influenced by geopolitical tensions and inflation reports.

10 aug 2026, 19:46 UTC

OPKO Health Inc. shares are trading higher amid broader market uncertainty, reflecting notable strength above its 20-day moving average since Friday's close.

7 aug 2026, 23:01 UTC

OPKO Health shares advanced in after-market trading, recovering from earlier losses amid broader market dynamics and a slight decline in the unemployment rate.

6 aug 2026, 19:16 UTC

OPKO Health Inc. shares are lower today amid notable volatility, with economic data showing initial jobless claims rose slightly ahead of tomorrow's non-farm payrolls report.

5 aug 2026, 23:01 UTC

OPKO Health shares are lower in after-market hours, reflecting broader market weakness amid recent economic data showing weaker-than-expected U.S. job growth.

4 aug 2026, 23:06 UTC

OPKO Health Inc. shares are higher in after-market trading, settling with a cumulative gain following a brief dip at the session's start.

3 aug 2026, 23:01 UTC

OPKO Health Inc shares increased in after-market trading, maintaining a steady rise since Monday's close amid a generally positive market backdrop.

31 jul 2026, 19:45 UTC

OPKO Health Inc. shares are trading roughly flat today, hovering around the middle of their one-month range and above the 20-day moving average.

30 jul 2026, 23:11 UTC

OPKO Health Inc. shares are lower in after-market hours, continuing a recent trend amid broader market uncertainty following the Federal Reserve's interest rate decision.

29 jul 2026, 23:46 UTC

No specific news was identified for OPKO Health Inc. Shares remained roughly flat during after-market hours, trading near unchanged since Wednesday's close.

Peer Vergelijking

Prijswijziging

OPKO Health Inc Prognose

Beoordelingsconsensus

By TipRanks

Moderate Buy

3 ratings

Buy

Hold

Sell

Gebaseerd op 3 analisten die aandelenratings hebben gegeven aan OPKO Health Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

60 / 339 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over OPKO Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.